Log In
Print
BCIQ
Print
Print this Print this
 

Edarbyclor, Azilsartan medoxomil/chlorthalidone

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionFixed-dose combination of azilsartan medoxomil, an angiotensin II type 1 (AT1) receptor blocker, and chlorthalidone, a long-acting oral thiazide-like diuretic
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Partner

Arbor Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today